The Best Legal Performance Enhancers & Why I’m Taking the BPC-157 Peptide
Thomas DeLauer walks through the preclinical research on BPC-157 and its proposed mechanisms, flags risks and the lack of human data, and shares his early personal experience.
Key moments
Tap a moment to play the video from there.
- 0:00Why DeLauer is covering BPC-157DeLauer says he has started experimenting with peptides and plans to cover safety, mechanisms, risks and the research on BPC-157.
- 1:43What a peptide isHe defines peptides as chains of amino acids that act through cell receptors, using insulin and GLP-1 drugs as examples.
- 2:55How BPC-157 is said to workHe describes a 15 amino acid chain from gut proteins that he says may raise growth hormone receptors and promote new blood vessel formation.
- 3:37Tendon study with a corticosteroidHe summarizes a preclinical study of a detached Achilles tendon, reporting better collagen, elasticity and function, and an override of a steroid's negative effect.
- 5:13Muscle crush injury studyHe describes a preclinical calf crush study in which daily dosing did better than a single large dose, and which again showed an override of the steroid.
- 6:38Angiogenesis as benefit and riskDeLauer calls new blood vessel formation central to recovery and also a potential risk, and says to discuss it with a doctor.
- 7:40Growth hormone receptor ideaHe explains a proposed mechanism in which BPC-157 increases growth hormone receptors without raising growth hormone itself.
- 8:41Abnormal tissue and VEGF concernHe warns that abnormal growth can build its own blood supply, so raising VEGF signaling could be problematic and should be vetted with a doctor.
- 9:32Review: promising, but no human dataHe cites a review reporting consistently positive tissue findings and low adverse reactions, while noting human data is lacking.
- 10:12His early personal experienceDeLauer says his doctor has him using it, and after about a week he has shoulder mobility he did not have before.
What the video says
Thomas DeLauer, a creator who says he is not a clinician, uses this solo video to explain why he has started using BPC-157, a peptide he describes as popular for injury repair and recovery. He opens with a short explainer on what peptides are, describing them as chains of amino acids that act through cell receptors. He gives insulin and GLP-1 drugs as familiar examples. A sponsor segment for a probiotic supplement sits near the start.
DeLauer describes BPC-157 as a 15 amino acid chain formed from protective proteins in the gut. He says its main proposed mechanism is increased blood vessel formation, which he ties to areas with limited blood flow such as the knees and Achilles. He also mentions possible anti-inflammatory effects under investigation. He then summarizes several preclinical studies. One looked at a fully detached Achilles tendon and, he says, found better collagen quality, elasticity, function and vasculature in the BPC-157 groups. Another used a crush injury to the calf muscle, and he reports that groups given BPC-157 daily did best. In both, he says BPC-157 overcame the slowing effect of a corticosteroid.
The second half covers mechanism and risk. DeLauer cites work showing more blood vessel density and a proposed effect on growth hormone receptors, which he compares to adding docks to a harbor. He says BPC-157 does not raise growth hormone itself. He then raises a caution: because the peptide appears to increase vascular growth factor signaling, he says abnormal tissue that builds its own blood supply could be a concern, and people should review this with a doctor. He cites a review that reported consistently positive tissue findings and few adverse reactions, while noting human data is lacking.
He closes with his own experience. He says his doctor has him using it for various injuries, that after a little over a week he has shoulder mobility he lacked before, and that this is anecdotal.
On each compound
BPC-1572:55
DeLauer describes BPC-157 as a 15 amino acid peptide from gut proteins. He cites preclinical work on tendon and muscle injury, proposed effects on blood vessel formation and growth hormone receptors, a possible concern with abnormal tissue, and a lack of human data.
See how your DNA reads BPC-157“again anecdotal so take it for what it's worth”
What this video doesn’t settle
- The studies described are preclinical, and the video gives no human trial data on BPC-157.
- The vascular growth concern is raised as a possibility, and the video does not say how large or likely the risk is.
- DeLauer's account of regaining shoulder mobility is one person's experience over about a week, with no control group.
Questions this video answers
How does BPC-157 work according to Thomas DeLauer?
DeLauer says its main proposed mechanism is increased blood vessel formation, which he links to recovery in areas with poor blood flow. He also describes a proposed increase in growth hormone receptors and possible anti-inflammatory effects still being investigated.
What research on BPC-157 does DeLauer cite?
He cites preclinical studies on a detached Achilles tendon and a crushed calf muscle, plus work on blood vessel density and growth hormone receptors. He also mentions a review that he says reported positive tissue findings and few adverse reactions.
What risks of BPC-157 does DeLauer mention?
He says the same blood vessel growth that may aid recovery is a potential risk, because abnormal tissue can build its own blood supply. He says to talk with a doctor before considering it and that human data is lacking.
Is there human evidence for BPC-157 in this video?
No. DeLauer says several times that the studies he discusses are preclinical and that human data is lacking. His only human account is his own experience over a little more than a week, which he calls anecdotal.
What is a peptide, according to this video?
DeLauer defines a peptide as a chain of amino acids in a specific sequence that acts on cell receptors and can influence cell behavior. He gives insulin and GLP-1 drugs as familiar examples.
Video by Thomas DeLauer on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
